Alpine Woods Capital Investors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.04M Sell
4,718
-166
-3% -$45.9K 0.23% 94
2026
Q1
$1.44M Sell
4,884
-2,607
-35% -$774K 0.35% 77
2025
Q4
$2.05M Sell
7,491
-1,513
-17% -$411K 0.49% 64
2025
Q3
$2.43M Hold
9,004
0.57% 53
2025
Q2
$2.48M Sell
9,004
-20
-0.2% -$5.44K 0.59% 60
2025
Q1
$2.39M Sell
9,024
-170
-2% -$41.9K 0.6% 60
2024
Q4
$2.14M Sell
9,194
-75
-0.8% -$17.2K 0.4% 78
2024
Q3
$2.09M Hold
9,269
0.37% 84
2024
Q2
$1.82M Hold
9,269
0.28% 96
2024
Q1
$1.94M Sell
9,269
-17,237
-65% -$3.62M 0.39% 88
2023
Q4
$5.58M Sell
26,506
-5,000
-16% -$1.07M 0.83% 44
2023
Q3
$6.31M Sell
31,506
-332
-1% -$66K 1.02% 34
2023
Q2
$5.9M Hold
31,838
0.92% 41
2023
Q1
$6.1M Sell
31,838
-2,100
-6% -$380K 0.92% 43
2022
Q4
$5.71M Sell
33,938
-4,715
-12% -$819K 0.83% 42
2022
Q3
$6.85M Hold
38,653
0.93% 42
2022
Q2
$7.91M Hold
38,653
0.99% 36
2022
Q1
$9.19M Sell
38,653
-20,140
-34% -$4.73M 0.97% 33
2021
Q4
$13.4M Hold
58,793
1.33% 17
2021
Q3
$11.4M Sell
58,793
-300
-0.5% -$60.8K 1.22% 19
2021
Q2
$12.6M Sell
59,093
-1,183
-2% -$250K 1.3% 13
2021
Q1
$12.3M Sell
60,276
-17,997
-23% -$3.54M 1.37% 13
2020
Q4
$14.3M Sell
78,273
-1,267
-2% -$215K 1.74% 7
2020
Q3
$13.3M Buy
79,540
+3,873
+5% +$652K 2.01% 6
2020
Q2
$12.3M Buy
75,667
+45
+0.1% +$8.07K 2.37% 5
2020
Q1
$13.1M Sell
75,622
-338
-0.4% -$67.3K 2.91% 4
2019
Q4
$15.2M Buy
75,960
+2
+0% +$410 2.89% 4
2019
Q3
$16.1M Sell
75,958
-9
-0% -$1.88K 2.96% 4
2019
Q2
$14.7M Sell
75,967
-6
-0% -$1.11K 3.06% 3
2019
Q1
$12.5M Buy
75,973
+309
+0.4% +$54.6K 2.72% 5
2018
Q4
$14.2M Buy
75,664
+29
+0% +$5.36K 3.42% 2
2018
Q3
$12.9M Buy
75,635
+35
+0% +$5.89K 2.65% 5
2018
Q2
$12.4M Sell
75,600
-8,000
-10% -$1.31M 2.7% 5
2018
Q1
$13.5M Sell
83,600
-300
-0.4% -$47.8K 0.72% 48
2017
Q4
$12.3M Hold
83,900
0.61% 57
2017
Q3
$11.4M Hold
83,900
0.58% 65
2017
Q2
$10.5M Hold
83,900
0.56% 67
2017
Q1
$9.97M Buy
83,900
+1,000
+1% +$120K 0.53% 72
2016
Q4
$9.56M Sell
82,900
-1,100
-1% -$122K 0.53% 71
2016
Q3
$8.78M Sell
84,000
-3,100
-4% -$324K 0.49% 76
2016
Q2
$8.48M Buy
87,100
+3,600
+4% +$340K 0.51% 70
2016
Q1
$8.02M Hold
83,500
0.47% 78
2015
Q4
$7.57M Buy
83,500
+1,500
+2% +$141K 0.41% 77
2015
Q3
$7.61M Hold
82,000
0.41% 78
2015
Q2
$7.63M Sell
82,000
-500
-0.6% -$46.6K 0.39% 87
2015
Q1
$7.81M Sell
82,500
-6,500
-7% -$602K 0.4% 83
2014
Q4
$7.89M Sell
89,000
-4,525
-5% -$383K 0.4% 81
2014
Q3
$7.48M Sell
93,525
-8,300
-8% -$625K 0.4% 79
2014
Q2
$7.22M Sell
101,825
-2,800
-3% -$197K 0.19% 87
2014
Q1
$7.74M Sell
104,625
-4,500
-4% -$339K 0.43% 77
2013
Q4
$8.56M Sell
109,125
-5,800
-5% -$454K 0.49% 68
2013
Q3
$8.49M Sell
114,925
-200
-0.2% -$14.7K 0.52% 66
2013
Q2
$8.74M Buy
+115,125
New +$7.55M 0.56% 61

Other funds holding CME

Alpine Woods Capital Investors's CME Position: Q2 2026 in Review

Alpine Woods Capital Investors reduced its CME Group (CME) stake by 3.4% in Q2 2026, selling an estimated $45.9K and leaving 4,718 shares worth $1.04M. The position accounts for 0.23% of the portfolio, ranked #94.

Alpine Woods Capital Investors first reported a position in CME in Q2 2013 and has held it in 53 quarters since. The position peaked at $16.1M in Q3 2019. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Alpine Woods Capital Investors held 4,718 shares of CME Group worth $1.04M as of Q2 2026.
  • Alpine Woods Capital Investors sold 166 CME Group shares in Q2 2026, an estimated $45.9K.
  • CME Group made up 0.23% of Alpine Woods Capital Investors's portfolio in Q2 2026, its #94 holding.
  • Alpine Woods Capital Investors first reported a position in CME Group in Q2 2013 and has held it in 53 quarters since.
  • Alpine Woods Capital Investors's CME Group position peaked at $16.1M in Q3 2019.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Alpine Woods Capital Investors's 13F filing for Q2 2026, filed 7 Aug 2026.